Liquidia Corp Investor Relations Material
Latest events
Q4 2023
Liquidia Corp
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Liquidia Corp
Access all reports
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina. It has subsidiary offices throughout North America and Europe.
Key slides for Liquidia Corp
J.P. Morgan 42nd Annual Healthcare Conference 2024
Liquidia Corp
J.P. Morgan 42nd Annual Healthcare Conference 2024
Liquidia Corp
Latest articles
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Deere & Company: Shaping Agriculture & Construction Since 1837
Exploring Deere & Company: A global leader in agriculture & construction equipment since 1837.
28 Mar 2024
Jane Fraser: First Female Leader of a Major Wall Street Bank
Discover the journey of Jane Fraser, CEO of Citigroup and the first female leader of a major Wall Street bank.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States